Medical News

RSS

Many health plans offer only limited coverage - if at all - for alternative therapies

"Most individuals with private insurance have little, if any, coverage for alternative medicine." People with "employer-based insurance often have some coverage," but it is typically limited to only certain treatments "and comes with more stipulations — like higher deductibles and preauthorization — than traditional care.

28 Sep 2010

Congressional races taking shape around health reform positions

Some Democrats are maintaining an independent voice on the issue of health reform. "Aware that their stock has taken the same tumble as home values, Congress' most vulnerable Democrats are declaring their independence from their party's agenda in Facebook profiles, television advertisements, news interviews and campaign websites leading up to the Nov. 2 election. That's when Republicans hope to retake control of the House they lost four years ago."

28 Sep 2010

As they consolidate, hospitals get pricier

Kaiser Health News staff writer Julie Appleby, working in collaboration with The Washington Post, reports From their base in Baltimore, leaders of Johns Hopkins Medicine can see the future and it's at the hospital down the road.

28 Sep 2010

Japanese Patent Office issues patent for ZIOPHARM Oncology's darinaparsin

ZIOPHARM Oncology, Inc. today announced that the Japanese Patent Office has issued a patent, Patent No. 4,571,408, with claims covering pharmaceutical compositions, including oral formulations, of various organic arsenic compounds, including darinaparsin (Zinapar or ZIO-101), and the use of these compositions and the organic arsenic compounds for the treatment of cancer, including as part of a combination therapy.

28 Sep 2010

State Roundup: N.Y. small businesses protest health insurance premium hikes; Arizona Medicaid crisis; a new payment system for Massachusetts?

Massachusetts officials are reviving the state's ambitious plan to change how doctors and hospitals are paid, aiming to hand the Legislature a specific proposal by Jan. 1 to end disagreement over controlling health spending.

28 Sep 2010

Voters still confused about health law

As the midterm election rhetoric intensifies, so does the voter confusion about the landmark federal health law passed last March, according to the tracking poll by the Kaiser Family Foundation.

28 Sep 2010

Valeant Pharmaceuticals completes merger of Biovail Corporation

Valeant Pharmaceuticals International, Inc. today announced the completion of the merger of Biovail Corporation and Valeant Pharmaceuticals International following the approval of the merger by shareholders of both companies.

28 Sep 2010

Women & Infants Hospital receives $2.1M NIH grant to continue work under COBRE for Perinatal Biology

Women & Infants Hospital has recently received a $2.1 million grant from the National Institutes of Health to continue work under the Center of Biomedical Research Excellence for Perinatal Biology. Of the 108 COBREs across the country, Women & Infants is the only one specifically focused on developmental research.

28 Sep 2010

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic low back pain have been published online by Expert Opinion on Pharmacotherapy. In addition, this study compared oxycodone controlled-release (CR) to placebo as an active control.

28 Sep 2010

Senate Republicans examining health reform's effect on Medicare advantage

A quartet of Senate Republicans is calling on Medicare's top accountant to release the numbers behind his analysis of health reform's impact on the Medicare Advantage program. The lawmakers ... say the steep cuts to MA under the new reform law will cause many plans to fold, while many others will be forced to drop benefits to remain profitable.

28 Sep 2010

Bayer’s new oral contraceptive receives FDA approval

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved a new oral contraceptive, Beyaz (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets).

28 Sep 2010

NPL, Orla receives fund to improve detection methods for TB

Two UK companies have been awarded joint funding for a research project that could see significant advances in the quest to aid detection and eradication of Tuberculosis (TB), across the world.

28 Sep 2010

Onconova Therapeutics to present Ex-RAD radioprotectant data at RRS Annual Meeting

Onconova Therapeutics, Inc. is presenting new data in five posters and an oral presentation this week summarizing several studies with the company's radioprotectant Ex-RAD- at the 56th Annual Meeting of the Radiation Research Society (RRS), September 25-29 in Maui, Hawaii.

28 Sep 2010

RPSPP for health benefits accepted into federal program

Governor Edward G. Rendell announced today that the Retired Pennsylvania State Police Program for health benefits has been accepted into a federal program to help offset the rising health care costs for retirees.

28 Sep 2010

Report: Workers' medical costs projected to jump next year by more than 12 percent

Health care bills for an average employee are slated to climb more than $486 next year, a 12.4 percent increase from this year, according to a study by Hewitt Associates.

28 Sep 2010

Southridge, Curaxis Pharmaceutical announce $25 million equity purchase agreement

Stephen Hicks, Chairman and CEO, of Southridge LLC and Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp , jointly announced a $25 million equity purchase agreement with Southridge Partners II, an institutional investor.

28 Sep 2010

Viridis BioPharma receives approval to manufacture, market NIMBUS antimicrobial technology in India

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that its proprietary NIMBUS antimicrobial technology has been approved for manufacture, marketing and sale in India. Viridis BioPharma, an India-based manufacturer and marketer of medical devices, received approval by the Food and Drug Administration of India to manufacture and market gauze wound dressings that incorporate NIMBUS antimicrobial technology.

28 Sep 2010

Study may provide new developing approaches to treat age-related osteoporosis

Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.

28 Sep 2010

Pfizer ceases SUN 1120 Phase 3 trial of SUTENT in men with CRPC

Pfizer Inc. announced today the discontinuation of the SUN 1120 Phase 3 trial evaluating SUTENT (sunitinib malate) in combination with prednisone for men with advanced castration-resistant prostate cancer that had progressed despite treatment with a docetaxel-based chemotherapy regimen. During a scheduled interim analysis, an independent Data Monitoring Committee found that the combination of sunitinib with prednisone was unlikely to improve overall survival when compared to prednisone alone.

28 Sep 2010

Oxygen Biotherapeutics to showcase DERMACYTE oxygen-rich skin care products at Spa & Resort expo

Oxygen Biotherapeutics, Inc. will showcase for the first time its DERMACYTE oxygen-rich skin care products at the Spa & Resort/Medical Aesthetics Spa Conference and Expo at the Jacob K. Javits Convention Center in New York City starting tomorrow.

28 Sep 2010

Medical News

Many health plans offer only limited coverage - if at all - for alternative therapies

Congressional races taking shape around health reform positions

As they consolidate, hospitals get pricier

Japanese Patent Office issues patent for ZIOPHARM Oncology's darinaparsin

State Roundup: N.Y. small businesses protest health insurance premium hikes; Arizona Medicaid crisis; a new payment system for Massachusetts?

Voters still confused about health law

Valeant Pharmaceuticals completes merger of Biovail Corporation

Women & Infants Hospital receives $2.1M NIH grant to continue work under COBRE for Perinatal Biology

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

Senate Republicans examining health reform's effect on Medicare advantage

Bayer’s new oral contraceptive receives FDA approval

NPL, Orla receives fund to improve detection methods for TB

Onconova Therapeutics to present Ex-RAD radioprotectant data at RRS Annual Meeting

RPSPP for health benefits accepted into federal program

Report: Workers' medical costs projected to jump next year by more than 12 percent

Southridge, Curaxis Pharmaceutical announce $25 million equity purchase agreement

Viridis BioPharma receives approval to manufacture, market NIMBUS antimicrobial technology in India

Study may provide new developing approaches to treat age-related osteoporosis

Pfizer ceases SUN 1120 Phase 3 trial of SUTENT in men with CRPC

Oxygen Biotherapeutics to showcase DERMACYTE oxygen-rich skin care products at Spa & Resort expo

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News